Phibro Animal Health (PAHC) Stock Price, News & Analysis

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PAHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PAHC, but not buy additional shares or sell existing shares.
View PAHC analyst ratings or view top-rated stocks.

3 brokers have issued twelve-month target prices for Phibro Animal Health's shares. Their PAHC share price targets range from $9.00 to $21.00. On average, they anticipate the company's stock price to reach $15.33 in the next twelve months. This suggests a possible upside of 19.1% from the stock's current price.
View analysts price targets for PAHC or view top-rated stocks among Wall Street analysts.

Phibro Animal Health's stock was trading at $11.58 at the start of the year. Since then, PAHC shares have increased by 11.1% and is now trading at $12.87.
View the best growth stocks for 2024 here.

Phibro Animal Health saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 706,200 shares, a drop of 17.5% from the March 15th total of 855,800 shares. Based on an average trading volume of 145,000 shares, the days-to-cover ratio is currently 4.9 days. Currently, 3.5% of the company's shares are sold short.
View Phibro Animal Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our PAHC earnings forecast.

Phibro Animal Health Co. (NASDAQ:PAHC) issued its quarterly earnings data on Wednesday, February, 7th. The company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.06. The business had revenue of $249.90 million for the quarter, compared to the consensus estimate of $242.91 million. Phibro Animal Health had a trailing twelve-month return on equity of 16.67% and a net margin of 1.51%.

Phibro Animal Health announced a quarterly dividend on Tuesday, February 6th. Stockholders of record on Wednesday, March 6th will be given a dividend of $0.12 per share on Wednesday, March 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.73%. The ex-dividend date of this dividend is Tuesday, March 5th.
Read our dividend analysis for PAHC.

Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 3.63%. The dividend payout ratio is 133.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, PAHC will have a dividend payout ratio of 39.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PAHC.

iShares U.S. Pharmaceuticals ETF holds 27,932 shares of PAHC stock, representing 0.11% of its portfolio.

Phibro Animal Health updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided EPS guidance of 1.040-1.160 for the period, compared to the consensus EPS estimate of 1.070. The company issued revenue guidance of $980.0 million-$1.0 billion, compared to the consensus revenue estimate of $990.3 million.

4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).

Phibro Animal Health's stock is owned by a number of institutional and retail investors. Top institutional investors include Bridge City Capital LLC (0.34%), Cardinal Capital Management (0.13%) and Los Angeles Capital Management LLC (0.07%).
View institutional ownership trends.

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.